Panavir rectal supp. 0.2mg #5

Instruction for Panavir rectal suppositories

You can buy rectal suppositories Panavir on this page

Composition

active ingredient - Panavir (Solanum tuberosum shoots polysaccharides) - 200 µg;
excipients: confectionary fat or solid fat 1,0198 g, paraffin - 0.0900 g, emulsifier T-2 - 0.0900 g.
Mass suppository - 1.2,

DESCRIPTION

Suppositories from white to white with a yellowish tinge, cone-shaped or cylindrical in shape, yellowish-gray blotches are allowed, odorless.
PHARMACOTHERAPE TREATMENT GROUP:
Antiviral and immunomodulating agent.
ATC CODE: J05AX.

Pharmacodynamics

Panavir rectal suppositories - purified extract of the shoots of the plant Solanum tuberosum; The main active ingredient is hexose glycoside, consisting of glucose, rhamnose, arabinose, mannose, xylose, galactose, uronic acids.
Panavir rectal suppositories are an antiviral and immunomodulatory agent. Increases the body’s non-specific resistance to various infections and contributes to the induction of interferon alpha and gamma leukocytes in the blood.
At therapeutic doses, Panavir rectal suppositories are well tolerated.
Tests have shown the absence of mutagenic, teratogenic, carcinogenic, allergenic and embryotoxic action. In preclinical studies on laboratory animals, negative effects on reproductive function and fetal development have not been established.
It has anti-inflammatory properties on the model of experimental exudative edema.

Pharmacokinetics

Pharmacokinetics of Panavir rectal suppositories has not been studied due to its chemical nature and low effective doses.

INDICATIONS FOR USE

• Herpes virus infections of various localization (including recurrent genital herpes, herpes Zoster and ophthalmic herpes);
• Secondary immunodeficiency states on the background of infectious diseases.
• Cytomegalovirus infection, including in patients with recurrent miscarriage. It is used in women with chronic viral infection and interferon deficiency at the stage of preparation for pregnancy.
• Papillomavirus infection (anogenital warts) as part of complex therapy.
• Tick-borne encephalitis in order to reduce viral load and relieve neurological symptoms (anisoreflexia, reduce reflexes, painful exit points of the cranial nerves, nystagmus) as part of complex therapy.
• SARS and influenza as part of complex therapy.

CONTRAINDICATIONS

• Hypersensitivity.
• Pregnancy.
• Lactation period.
• Childhood.

APPLICATION DURING BREASTFEEDING

If necessary, the use of Panavir rectal suppositories during lactation breastfeeding at the time of taking the drug should be discontinued.

METHOD OF ADMINISTRATION AND DOSES

Rectally.
For the treatment of herpes virus infections and tick-borne encephalitis, 1 suppository is applied twice with an interval of 48 or 24 hours. If necessary, the treatment can be repeated after 1 month.
For the treatment of cytomegalovirus and human papillomavirus infections, 1 suppository is used three times during the first week with an interval of 48 hours and two times during the second week with an interval of 72 hours.
For the treatment of SARS and influenza, 1 suppository is applied every 24 hours for 5 days.

Side effects of Panavir rectal suppositories

Panavir rectal suppositories are well tolerated, possible complications may be associated with individual intolerance and hypersensitivity to the drug.
However, if any undesirable side effects appear, it is necessary to stop administering the drug and consult a doctor.
If you notice any other side effects that are not listed in the instructions, inform your doctor.

OVERDOSE

Cases of overdose are not registered. The results of preclinical studies indicate a low toxicity of Panavir rectal suppositories.

INTERACTION WITH OTHER MEDICINES

Not registered.

INFLUENCE ON THE ABILITY TO MANAGE THE VEHICLES, MECHANISMS

Data on the possibility of a negative effect of the drug on the ability to drive vehicles and the implementation of potentially hazardous activities that require special attention and speed of psychomotor reactions are not available.

FORM OF ISSUE

Rectal suppositories 200 mcg.
5 suppositories in a blister pack, 1 or 2 blister packs together with the instructions for use in a carton pack.

STORAGE CONDITIONS

In a dry, dark place at a temperature of from 2 to 8 ° C.
Keep out of the reach of children.
SHELF LIFE - 3 years.
Do not use after the expiration date printed on the package.

Terms of sell

You can buy Panavir rectal suppositories without a prescription.